AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹799 Cr | ₹2,169 Cr | ₹-1,021 Cr | ₹223 Cr | ₹-1,164 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹799 Cr |
| Mar2025 | ₹2,169 Cr |
| Mar2024 | ₹-1,021 Cr |
| Mar2023 | ₹223 Cr |
| Mar2022 | ₹-1,164 Cr |
How is Net Cash Inflow / Outflow of AUROBINDO PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹799 Cr | -63.17 | |
| Mar2025 | ₹2,169 Cr | Positive | |
| Mar2024 | ₹-1,021 Cr | Negative | |
| Mar2023 | ₹223 Cr | Positive | |
| Mar2022 | ₹-1,164 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹95,516.4 Cr | -2.5% | 1.2% | 48.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -2.5% |
1.2% |
48.2% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses